Investor's Business Daily on MSN20m
Perdoceo Education Stock Got A IBD RS Rating Lift
Perdoceo Education shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 89.
Griffon shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 64 to 88.
Costco is the IBD Stock Of The Day as it pulls back near a buy point after an impressive run in 2024. On Wednesday, analysts ...
Scientists at UMC Utrecht have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal ...
Coinbase and fellow Class of 2021 IPO Duolingo lead 21 names flagged by this stock screener, including Taser maker Axon ...
Sony Entertainment Television is all set to premiere its much-anticipated dance competition, India’s Best Dancer vs. Super ...
P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...
"Or colitis or Crohn's type IBD or even a birth trauma. Like these stories are much more relevant, I feel as a double bagger, ...
Breaking away from a commoditized and homogenous IBD model, Cetera offers financial professionals and institutions the latest solutions, support, and services to grow, scale, or transition with a ...
November 14, 2024--(BUSINESS WIRE)--Thetis Pharmaceuticals, LLC ("Thetis"), a pharmaceutical company developing an oral, small molecule Resolvin E1 (RvE1) drug targeting the BLT1 receptor to treat ...
A rising RS line means that a stock is outperforming the S&P 500 index. IBD named Nu as Stock Of The Day on Oct. 28. Warren ...
Announced development of SL-325, a first-in-class antagonist antibody to DR3, the receptor for TL1A; IND filing expected in Q3'2025 – – Cash ...